Prelude Capital Management’s Royalty Pharma RPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$966K Buy
2025
Q1
$804K Buy
2024
Q2
Sell
2024
Q1
$694K Buy
2023
Q3
Sell
2023
Q2
$490K Buy
2023
Q1
$540K Hold
2022
Q4
$593K Buy
2022
Q2
Sell
2022
Q1
$356K Buy
2021
Q4
Sell
2021
Q3
$237K Buy